nacfc 2021 | w28: systems for developing and testing therapeutic strategies
Published 2 years ago • 40 plays • Length 1:59:40Download video MP4
Download video MP3
Similar videos
-
2:00:37
nacfc 2021 | s28: clinical advancements in modulator therapy
-
1:55:52
nacfc 2022 | w28: clinical genetics and beyond
-
2:01:33
nacfc 2021 | restoring cftr when there is none: emerging strategies to overcome refractory variants
-
2:38
nacfc 2021 | delivery challenges animation
-
1:51:16
nacfc 2021 | w29: therapies beyond cftr
-
2:02:22
nacfc 2021 | s09: highly effective cftr modulators in the post-fda approval world
-
1:11:20
cf foundation | nacfc highlights and q a
-
1:58:25
nacfc 2022 | s31: stronger together: updates from international clinical trials
-
57:53
nacfc 2020 | plenary 1: laying the foundation for the path to a cure
-
1:52:33
nacfc 2021 | w06: nutrition research
-
1:14:39
nacfc 2021 | s07: cftr, a member of a molecular community
-
1:54:09
nacfc 2021 | w21: airway inflammation and repair
-
1:16:06
nacfc 2020 | s27: challenges of precision medicine in cystic fibrosis
-
1:59:43
nacfc 2021 | s04: the new era of highly effective cftr modulator therapy
-
1:16:43
nacfc 2021 | w36: pt/rt research year in review
-
1:17:35
nacfc 2020 | discipline group 2: optimizing cystic fibrosis nutrition care in a new era
-
1:42:08
nacfc 2021 | w30: epidemiology and management of cystic fibrosis airway infections
-
1:45:15
nacfc 2021 | w13: quality improvement framework for change: networks, education, and engagement
-
59:58
nacfc 2021 | plenary 3: expanding the horizon of therapies for the underlying cause of cf